OQO — Herpes Simplex Virus Nucleic Acid Amplification Assay Class II

FDA Device Classification

Classification Details

Product Code
OQO
Device Class
Class II
Regulation Number
866.3305
Submission Type
Review Panel
MI
Medical Specialty
Microbiology
Implant
No

Definition

A polymerase chain reaction (pcr)-based qualitative in vitro diagnostic test for the detection and typing of herpes simplex virus (hsv) dna using vaginal swab specimens.

Recent 510(k) Clearances

K-NumberApplicantDevice NameDate
K172509vela diagnostics usaSentosa SA201 HSV 1/2 Qualitative PCR TestFebruary 1, 2018
K162673hologicAptima Herpes Simplex Viruses 1 & 2 AssayJune 15, 2017
K150962focus diagnosticsSimplexa HSV 1 & 2 Direct, Simplexa HSV 1 & 2 Positive Control PackAugust 28, 2015
K150617roche molecular systemscobas HSV 1 and 2 TestJune 1, 2015
K142156seegeneSEEGENE ANYPLEX II HSV-1/2 ASSAYFebruary 13, 2015
K142738qiagenartus HSV-1/2 QS-RGQ MDx KitDecember 19, 2014
K140198intelligent medical devicesIMDX HSV-1/2 FOR ABBOTT M2000May 13, 2014
K140029quidel corporationAMIPLIVUE HSV 1&2 ASSAYMarch 26, 2014
K111951biohelix corporationISOAMP HSV ASSAYSeptember 27, 2011
K111527eragen biosciencesMULTICODE-RTX HERPES SIMPLEX VIRUS 1 & 2 KITAugust 3, 2011
K103798becton, dickinson andBD PROBETEC HERPES SIMPLEX VIRUSES (HSV 1& 2) Q AMPLIFIED DNA ASSAYSMarch 18, 2011
K100336eragen biosciencesMULTICODE - RTX HERPES SIMPLEX VIRUS 1 AND 2 KIT, MODEL 3711May 12, 2010